Fulgent Genetics (FLGT) Notes Payables (2021 - 2025)
Historic Notes Payables for Fulgent Genetics (FLGT) over the last 5 years, with Q3 2025 value amounting to $476000.0.
- Fulgent Genetics' Notes Payables rose 1553.4% to $476000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $476000.0, marking a year-over-year increase of 1553.4%. This contributed to the annual value of $412000.0 for FY2024, which is 6517.33% down from last year.
- As of Q3 2025, Fulgent Genetics' Notes Payables stood at $476000.0, which was up 1553.4% from $476000.0 recorded in Q2 2025.
- Fulgent Genetics' 5-year Notes Payables high stood at $6.1 million for Q1 2022, and its period low was $412000.0 during Q2 2024.
- In the last 5 years, Fulgent Genetics' Notes Payables had a median value of $2.9 million in 2023 and averaged $3.1 million.
- In the last 5 years, Fulgent Genetics' Notes Payables tumbled by 9263.55% in 2024 and then skyrocketed by 1553.4% in 2025.
- Over the past 5 years, Fulgent Genetics' Notes Payables (Quarter) stood at $5.9 million in 2021, then dropped by 4.42% to $5.6 million in 2022, then tumbled by 79.02% to $1.2 million in 2023, then tumbled by 65.17% to $412000.0 in 2024, then rose by 15.53% to $476000.0 in 2025.
- Its Notes Payables was $476000.0 in Q3 2025, compared to $476000.0 in Q2 2025 and $476000.0 in Q1 2025.